Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by yowkonasaearthon Mar 04, 2021 8:35am
141 Views
Post# 32713132

Nickel's Update as of Today

Nickel's Update as of TodaySponsored Post Why do you think there could be a potential demand for Nickel and Lithium in the First Place? Lets take a look in this updated information here. Try to click this one!

It is said that, these metals are not getting enough recognition as they should. There expanding demand for electric vehicles (EVs) in an inflation climate-conscious worldwide society. According to the news, total EV demand could potentially move from about approx. 2.5 million in 2020 to approximately 11.2 million in 2025, then reach around approx. 31.1 million by 2030. It is no wonder that these other companies are now the most valuable automaker in the world in terms of market cap.

But what do you think is powering these cars? Do you have any idea? Check disclaimer on profile and landing page.
<< Previous
Bullboard Posts
Next >>